Policy

Planned Supervised Injection Facility Hits Roadblock in U.S. Circuit Court
A U.S. Circuit Court of Appeals has ruled, 2-1, that Philadelphia not-for-profit Safehouse would be in violation of federal law if it were to open a supervised injection facility.
HHS Eliminates X-Waiver Requirement for DEA-Licensed Physicians
HHS is publishing new guidelines that will expand access to medication-assisted treatment for opioid use disorder by exempting physicians from certain certification requirements necessary for prescribing buprenorphine.
Despite Recommendation, New Dietary Guidelines on Alcohol Consumption Unchanged
The latest edition of the Dietary Guidelines for Americans, jointly released by the federal departments of Agriculture and Health and Human Services, maintain the guidance on alcohol consumption found in previous versions of the document, despite recommendations last June from an expert advisory committee.
Stimulant Summit: Fentanyl Looms, but Stimulants Pose Increasing Threat in Northeast
Fentanyl remains the No. 1 illicit substance threat in Vermont, but multiple trends point to cocaine and methamphetamine becoming increasingly prevalent within the state, drug intelligence officer James Downes, MS, and public health analyst Stephanie Thompson, MPA of the Vermont Intelligence Center said in a session presented Friday.
Behavioral Health Changes Under Biden Could Hinge on Senate Outcome
Former Vice President Joe Biden appears to have won the presidential election, but behavioral healthcare leaders say significant changes for the field could depend on the results of still-undecided Senate races.
Significant BH Implications in Incoming Administration's Proposed Relief Plan
The $1.9 trillion relief and recovery package proposed by the incoming administration of President-elect Joe Biden and Vice President-elect Kamala Harris includes items that can benefit behavioral healthcare in innumerable ways.
Is Healthcare a Right, and Is Our Field Included?
Socioeconomic analyses of our healthcare system are plentiful, yet the historical and legal basis for how and why we provide healthcare is less discussed.
DEA Announces Two Historic Drug Busts in Southern California
Authorities in Los Angeles and San Diego have conducted record-setting seizures of cocaine, heroin, crystal meth and fentanyl within the past two weeks.
FDA Seeks Public Input on Patient-Focused Drug Development for Stimulant Use Disorder
The FDA will conduct a virtual public meeting on patient-focused drug development for stimulant use disorder on Oct. 6, and is seeking input from individuals and families impacted by stimulant use.
State and County Budget Shortfalls to Reach Almost $650 Billion
State, county and local government financial shortfalls are reaching dangerous levels as these entities continue to respond to the COVID-19 pandemic.
HEAL Initiative Slowed by COVID-19, but NIH Still Making Advances
With much of the research in the Helping to End Addiction Long-term Initiative temporarily on pause, NIH Director Francis Collins, MD, PhD, and Nora Volkow, MD, director of the National Institute on Drug Abuse, shared with Rx Summit attendees other areas of progress for NIH.

Videos

Video: ONC’s Scott Weinstein outlines the Data Segmentation for Privacy (DS4P) initiative

ONC fellow discusses current privacy initiatives being explored in federal health IT effort

Back to Top